Molecular mechanisms underlying the epigallocatechin-3-gallate-mediated inhibition of oral squamous cell carcinogenesis
- 5 June 2023
- journal article
- research article
- Published by Elsevier in Archives of Oral Biology
- Vol. 153, 105740
Abstract
No abstract availableKeywords
Funding Information
- Chinese Academy of Meteorological Sciences
- National Key Clinical Specialty Discipline Construction Program of China (PKUSSNKP-202102)
- CAMS Innovation Fund for Medical Sciences (2019-I2M-5-038)
- National Natural Science Foundation of China (81300894, 81671006)
This publication has 75 references indexed in Scilit:
- GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkitBioinformatics, 2013
- (−)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cellsChemico-Biological Interactions, 2010
- Green tea polyphenols for prostate cancer chemoprevention: A translational perspectivePhytomedicine, 2010
- A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallateBritish Journal of Cancer, 2008
- Green tea (Camellia sinensis) and cancer prevention: a systematic review of randomized trials and epidemiological studiesChinese Medicine, 2008
- Tea and cancer prevention: Molecular mechanisms and human relevanceToxicology and Applied Pharmacology, 2007
- Nomenclature and classification of potentially malignant disorders of the oral mucosaJournal of Oral Pathology & Medicine, 2007
- Announcing the worldwide Protein Data BankNature Structural & Molecular Biology, 2003
- Inhibition of Carcinogenesis by TeaAnnual Review of Pharmacology and Toxicology, 2002
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000